No Detail Found!

Association of Endothelial Nitric Oxide Synthase (eNOS) gene polymorphism (Glu 298 Asp) with coronary artery disease in subjects from Multan, Pakistan.

Author(s)
Asia Taqddus Institute of Pure and Applied Biology, Zoology Division, Bahauddin Zakariya University, Multan, Pakistan
Abu Bakar Ali Saa Chaudry Pervaiz Ellahi Institute of Cardiology, Multan, Pakistan
Burhan Pasha Cardiology Ward, Bakhtawar Amin Memorial Hospital, Multan, Pakistan
Muhammad Latif Institute of Pure and Applied Biology, Zoology Division, Bahauddin Zakariya University, Multan, Pakistan
Sohail Safdar PMRC Research Center, Nishter Medical College, Multan, Pakistan
Rehan Sadiq Shaikh Institute of Biotechnology, Bahauddin Zakariya University, Multan, Pakistan
Muhammad Ali Institute of Biotechnology, Bahauddin Zakariya University, Multan, Pakistan
Furhan Iqbal Institute of Pure and Applied Biology, Zoology Division, Bahauddin Zakariya University, Multan, Pakistan
Abstract
Acute Coronary Syndrome (ACS) is the most common disease and cause of mortality in both genders across the world and certain risk factors i.e. age, gender, smoking, diabetes, hypertension, drugs usage, weight etc are known to be associated with the disease. The aim of this study was to find if there is any correlation exists between ACS and hereditary genetic defect in endothelial nitric oxide synthase (ecNOS) gene as eNOS generates Nitric oxide in blood vessels and regulates the vascular tone hence directly affecting the cardiovascular function. Single nucleotide polymorphism (SNP) (Glu 298 Asp) in ecNOS was determined in 280 subjects, from Southern Punjab (in Pakistan) population, including (160 ACS patients and 120 healthy controls) by PCR–RFLP method and genotype was correlated with various risk factors as well as with serum cholesterol and triglyceride levels. Our results indicated that the genotype Glu 298 Asp was not associated with ACS but when various studied parameters were compared among patients suffering from various forms of ACS and their healthy controls, it was observed that age (45-55 years) (P = 0.05), gender (male) (P
Publication Details
Page(s) 357-363
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 27, Issue: 2, Year: 2014

Request the full text from PASTIC

0

Citations

0

Downloads

190

Views